Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Apr 2022	119	Global Markets Direct	ASDR-600478

Published: Apr 2022 - Pages : 119 - Publisher : Global Markets Direct - Report code : ASDR-600478

Biogen Inc
CanBas Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Karyopharm Therapeutics Inc
Oita University Institute of Advanced Medicine Inc
Wigen Biomedicine Technology (Shanghai) Co Ltd

Exportin 1 - Pipeline Review, H2 2020

This report can be of interest as well:

Exportin 1 - Pipeline Review, H2 2020

Published: August, 2020 | Report code: ASDR-563703